恩西尼可碱是α7烟碱受体的选择性部分激动剂,正在进行III期临床试验,用于治疗精神分裂症的认知障碍。

清空选项
90407-16-2 7-Chloro-1-benzothiophene-2-carboxylic acid
BD11041390407-16-295%
¥2569.0025g常备现货
550998-56-6 Methyl 7-chlorobenzo[b]thiophene-2-carboxylate
BD201489550998-56-695%
¥303.001g常备现货
1